Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver

Journal of Virology

Volumn 82, Issue 19, 2008, Pages 9513-9524

  Inagaki, Katsuya ^a,c   Piao, Chuncheng ^a   Kotchey, Nicole M ^a   Wu, Xiaolin ^b   Nakai, Hiroyuki ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SAIC FREDERICK INC   (United States)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS 8 VECTOR; BETA GALACTOSIDASE; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOME ANALYSIS; LIVER; LIVER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; LIVER RESECTION; MALE; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; ANIMALS, NEWBORN; CELL LINE, TUMOR; DEPENDOVIRUS; GENOME, VIRAL; HEART; HEPATITIS; HEPATOCYTES; HUMANS; LIVER; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MUS;

EID: 52649092423     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01001-08     Document Type: Article

References (45)

1. Bilbao, R., D. P. Reay, J. Li, X. Xiao, and P. R. Clemens. 2005. Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1. Hum. Gene Ther. 16:678-684.
2. Bostick, B., A. Ghosh, Y. Yue, C. Long, and D. Duan. 2007. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 14:1605-1609.
3. Bouchard, S., T. C. MacKenzie, A. P. Radu, S. Hayashi, W. H. Peranteau, N. Chirmule, and A. W. Flake. 2003. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J. Gene Med. 5:941-950.
4. Chen, Z. Y., C. Y. He, L. Meuse, and M. A. Kay. 2004. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther. 11:856-864.
5. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156.
6. Cunningham, S. C., A. P. Dane, A. Spinoulas, and I. E. Alexander. 2008. Gene delivery to the juvenile mouse liver using AAV2/8 vectors. Mol. Ther. 16:1081-1088.
7. Daly, T. M., K. K. Ohlemiller, M. S. Roberts, C. A. Vogler, and M. S. Sands. 2001. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther. 8:1291-1298.
8. Donsante, A., D. G. Miller, Y. Li, C. Vogler, E. M. Brunt, D. W. Russell, and M. S. Sands. 2007. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477.
9. Duan, D., P. Sharma, J. Yang, Y. Yue, L. Dudus, Y. Zhang, K. J. Fisher, and J. F. Engelhardt. 1998. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:8568-8577.
10. Elliger, S. S., C. A. Elliger, C. Lang, and G. L. Watson. 2002. Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice. Mol. Ther. 5:617-626.
11. Gao, G., L. H. Vandenberghe, M. R. Alvira, Y. Lu, R. Calcedo, X. Zhou, and J. M. Wilson. 2004. Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78:6381-6388.
12. Gao, G. P., M. R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J. M. Wilson. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99:11854-11859.
13. Garrick, D., S. Fiering, D. I. Martin, and E. Whitelaw. 1998. Repeat-induced gene silencing in mammals. Nat. Genet. 18:56-59.
14. Ghosh, A., Y. Yue, C. Long, B. Bostick, and D. Duan. 2007. Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol. Ther. 15:750-755.
15. Grimm, D., S. Zhou, H. Nakai, C. E. Thomas, T. A. Storm, S. Fuess, T. Matsushita, R. Suroski, M. Lochrie, L. Meuse, A. McClelland, P. Colosi, and M. A. Kay. 2003. Pre-clinical evaluation of pseudotyped adeno-associated virus (AAV) vectors for liver gene therapy. Blood 102:2412-2419.
16. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
17. Hartung, S. D., J. L. Frandsen, D. Pan, B. L. Koniar, P. Graupman, R. Gunther, W. C. Low, C. B. Whitley, and R. S. McIvor. 2004. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene. Mol. Ther. 9:866-875.
18. Inagaki, K., S. Fuess, T. A. Storm, G. A. Gibson, C. F. McTiernan, M. A. Kay, and H. Nakai. 2006. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14:45-53.
19. Inagaki, K., S. M. Lewis, X. Wu, C. Ma, D. J. Munroe, S. Fuess, T. A. Storm, M. A. Kay, and H. Nakai. 2007. DNA palindromes with a modest arm length of ≤20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice. J. Virol. 81:11290-11303.
20. Inagaki, K., C. Ma, T. A. Storm, M. A. Kay, and H. Nakai. 2007. The role of DNA-PKcs and Artemis in opening viral DNA hairpin termini in various tissues in mice. J. Virol. 81:11304-11321.
21. Ledwith, B. J., S. Manam, P. J. Troilo, A. B. Barnum, C. J. Pauley, T. G. Griffiths II, L. B. Harper, C. M. Beare, W. J. Bagdon, and W. W. Nichols. 2000. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 43:258-272.
22. Lipshutz, G. S., D. Titre, M. Brindle, A. R. Bisconte, C. H. Contag, and K. M. Gaensler. 2003. Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol. Ther. 8:90-98.
23. Mah, C., K. O. Cresawn, T. J. Fraites, Jr., C. A. Pacak, M. A. Lewis, I. Zolotukhin, and B. J. Byrne. 2005. Sustained correction of glycogen storage disease type II using adeno-associated virus serotype 1 vectors. Gene Ther. 12:1405-1409.
24. Martienssen, R. A. 2003. Maintenance of heterochromatin by RNA interference of tandem repeats. Nat. Genet. 35:213-214.
25. Martin, T., S. E. Parker, R. Hedstrom, T. Le, S. L. Hoffman, J. Norman, P. Hobart, and D. Lew. 1999. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Hum. Gene Ther. 10:759-768.
26. McBurney, M. W., T. Mai, X. Yang, and K. Jardine. 2002. Evidence for repeat-induced gene silencing in cultured mammalian cells: inactivation of tandem repeats of transfected genes. Exp. Cell Res. 274:1-8.
27. McCarty, D. M., S. M. Young, Jr., and R. J. Samulski. 2004. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38:819-845.
28. Miller, D. G., L. M. Petek, and D. W. Russell. 2004. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36:767-773.
29. Miller, D. G., G. D. Trobridge, L. M. Petek, M. A. Jacobs, R. Kaul, and D. W. Russell. 2005. Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79:11434-11442.
30. Mitchell, R. S., B. F. Beitzel, A. R. Schroder, P. Shinn, H. Chen, C. C. Berry, J. R. Ecker, and F. D. Bushman. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
31. Nakai, H., S. Fuess, T. A. Storm, L. A. Meuse, and M. A. Kay. 2003. Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo. Mol. Ther. 7:112-121.
32. Nakai, H., S. Fuess, T. A. Storm, S. Muramatsu, Y. Nara, and M. A. Kay. 2005. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J. Virol. 79:214-224.
33. Nakai, H., R. W. Herzog, J. N. Hagstrom, J. Walter, S. H. Kung, E. Y. Yang, S. J. Tai, Y. Iwaki, G. J. Kurtzman, K. J. Fisher, P. Colosi, L. B. Couto, and K. A. High. 1998. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600-4607.
34. Nakai, H., Y. Iwaki, M. A. Kay, and L. B. Couto. 1999. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73:5438-5447.
35. Nakai, H., E. Montini, S. Fuess, T. A. Storm, L. Meuse, M. Finegold, M. Grompe, and M. A. Kay. 2003. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Mol. Ther. 7:101-111.
36. Nakai, H., T. A. Storm, and M. A. Kay. 2000. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18:527-532.
37. Nakai, H., C. E. Thomas, T. A. Storm, S. Fuess, S. Powell, J. F. Wright, and M. A. Kay. 2002. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J. Virol. 76:11343-11349.
38. Nakai, H., X. Wu, S. Fuess, T. A. Storm, D. Munroe, E. Montini, S. M. Burgess, M. Grompe, and M. A. Kay. 2005. Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79:3606-3614.
39. Nakai, H., S. R. Yant, T. A. Storm, S. Fuess, L. Meuse, and M. A. Kay. 2001. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75:6969-6976.
40. Pacak, C. A., C. S. Mah, B. D. Thattaliyath, T. J. Conlon, M. A. Lewis, D. E. Cloutier, I. Zolotukhin, A. F. Tarantal, and B. J. Byrne. 2006. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99:e3-e9.
41. Rucker, M., T. J. Fraites, Jr., S. L. Porvasnik, M. A. Lewis, I. Zolotukhin, D. A. Cloutier, and B. J. Byrne. 2004. Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131:3007-3019.
42. Schnepp, B. C., K. R. Clark, D. L. Klemanski, C. A. Pacak, and P. R. Johnson. 2003. Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J. Virol. 77:3495-3504.
43. Song, S., Y. Lu, Y. K. Choi, Y. Han, Q. Tang, G. Zhao, K. I. Berns, and T. R. Flotte. 2004. DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc. Natl. Acad. Sci. USA 101:2112-2116.
44. Wang, F., N. Koyama, H. Nishida, T. Haraguchi, W. Reith, and T. Tsukamoto. 2006. The assembly and maintenance of heterochromatin initiated by transgene repeats are independent of the RNA interference pathway in mammalian cells. Mol. Cell. Biol. 26:4028-4040.
45. Wang, Z., T. Zhu, C. Qiao, L. Zhou, B. Wang, J. Zhang, C. Chen, J. Li, and X. Xiao. 2005. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23:321-328.